ES469878A1 - Un procedimiento para preparar una composicion farmaceutica para el tratamiento del habito de consumir drogas - Google Patents

Un procedimiento para preparar una composicion farmaceutica para el tratamiento del habito de consumir drogas

Info

Publication number
ES469878A1
ES469878A1 ES469878A ES469878A ES469878A1 ES 469878 A1 ES469878 A1 ES 469878A1 ES 469878 A ES469878 A ES 469878A ES 469878 A ES469878 A ES 469878A ES 469878 A1 ES469878 A1 ES 469878A1
Authority
ES
Spain
Prior art keywords
tyrosine
alpha
methyl
para
drug addiction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES469878A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of ES469878A1 publication Critical patent/ES469878A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Un procedimiento para preparar una composición farmacéutica para el tratamiento del hábito de consumir drogas sin experimentar cristaluria, que comprende asociar una cantidad predeterminada terapéuticamente eficaz de alfa-metil-tirosina de la fórmula estructural **(Fórmula)** Y un agente alcalinizante en una cantidad suficiente para que, a la dosis administrada, provoque que la orina del paciente tenga un pH alcalino, preferiblemente superior a 7,4 y seguidamente llevar la composición obtenida a una forma de administración adecuada, tal como píldora, cápsula, solución para inyección y otras.
ES469878A 1977-05-16 1978-05-16 Un procedimiento para preparar una composicion farmaceutica para el tratamiento del habito de consumir drogas Expired ES469878A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/797,372 US4117161A (en) 1977-05-16 1977-05-16 Method of pharmacologically treating drug addiction with alpha-methyl-para-tyrosine

Publications (1)

Publication Number Publication Date
ES469878A1 true ES469878A1 (es) 1979-09-16

Family

ID=25170655

Family Applications (1)

Application Number Title Priority Date Filing Date
ES469878A Expired ES469878A1 (es) 1977-05-16 1978-05-16 Un procedimiento para preparar una composicion farmaceutica para el tratamiento del habito de consumir drogas

Country Status (5)

Country Link
US (1) US4117161A (es)
JP (1) JPS53142535A (es)
CA (1) CA1091155A (es)
ES (1) ES469878A1 (es)
IT (1) IT1104177B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5051426A (en) * 1990-03-27 1991-09-24 Parnell Pharmaceuticals, Inc. Method for effecting withdrawal from drug dependency
US5219858A (en) * 1990-03-27 1993-06-15 Parnell Pharmaceuticals, Inc. Method and compositions for effecting withdrawal from drug dependency
US20040167164A1 (en) * 1998-05-05 2004-08-26 Jose Pozuelo Compositions and methods for treating particular chemical addictions and mental illnesses
US20030049272A1 (en) * 2001-08-30 2003-03-13 Yatindra Joshi Pharmaceutical composition which produces irritation
RU2209062C1 (ru) * 2002-03-19 2003-07-27 Институт физиологии им. И.П.Павлова РАН Вещество, обладающее седативным действием
US10646552B2 (en) 2012-01-17 2020-05-12 Tyme, Inc. Pharmaceutical compositions and methods
US10272068B2 (en) 2012-01-17 2019-04-30 Tyme, Inc. Pharmaceutical compositions and methods
US20130183263A1 (en) 2012-01-17 2013-07-18 Steven Hoffman Pharmaceutical compositions and methods
US8481498B1 (en) 2012-01-17 2013-07-09 Steven Hoffman Pharmaceutical compositions and methods
US10813901B2 (en) 2013-10-22 2020-10-27 Yamo Pharmaceuticals Llc Compositions and methods for treating autism
US9326962B2 (en) 2013-10-22 2016-05-03 Steven Hoffman Compositions and methods for treating intestinal hyperpermeability
US9763903B2 (en) 2013-10-22 2017-09-19 Steven Hoffman Compositions and methods for treating intestinal hyperpermeability
US10751313B2 (en) 2013-10-22 2020-08-25 Yamo Pharmaceuticals Llc Compositions and methods for treating autism
US9585841B2 (en) 2013-10-22 2017-03-07 Tyme, Inc. Tyrosine derivatives and compositions comprising them
US11806326B2 (en) 2018-01-29 2023-11-07 Jonathan Sackner-Bernstein Methods for dopamine modulation in human neurologic diseases
RU2719575C1 (ru) * 2019-02-01 2020-04-21 Общество с ограниченной ответственностью "Центр ранней диагностики нейродегенеративных заболеваний (НДЗ)" Фармацевтическая композиция на основе альфа-метил-п-тирозина и способ ранней диагностики болезни Паркинсона
KR20220098682A (ko) 2019-05-14 2022-07-12 타임, 인크. 암을 치료하기 위한 조성물 및 방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2682871A (en) * 1970-03-24 1972-09-28 Sandler Merton Pharmaceutical compositions

Also Published As

Publication number Publication date
JPS53142535A (en) 1978-12-12
IT7849358A0 (it) 1978-05-15
CA1091155A (en) 1980-12-09
US4117161A (en) 1978-09-26
IT1104177B (it) 1985-10-21

Similar Documents

Publication Publication Date Title
ES469878A1 (es) Un procedimiento para preparar una composicion farmaceutica para el tratamiento del habito de consumir drogas
ES2089027T3 (es) Forma de dosificacion transmucosica.
IL99699A0 (en) Method of treating or preventing type 1 diabetes by oral administration of insulin
DE69230112D1 (de) Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin
ATE94393T1 (de) Dosisform zur oralen verabreichung des hypoglykaemischen glipizids.
ATE5852T1 (de) Therapeutische zusammensetzungen mit gesteigerter bioverfuegbarkeit und verfahren zu deren herstellung.
FI95653C (fi) Menetelmä lääkeaineen anto- ja/tai annostelumuodon valmistamiseksi
JPS6463522A (en) Pharmaceutical composition for treating and preventing gallstone and gall deficient indigestion
KR890006227A (ko) 페놀-함유 진해성 액체 조성물
ES449797A1 (es) Un procedimiento para preparar derivados de 1,3,8-tiazaspiro4,5 deon-4-ona.
MY100780A (en) Azumolene dosage form.
US3873709A (en) Method of treating psychosis
DE3344086A1 (de) Verwendung von azaspirogermanium-verbindungen zur behandlung von arthritis
WO2001049269A1 (en) Sustained-releasing anthelmintic compositions comprising praziquantel
KR930702985A (ko) 식도암의 치료
US3885030A (en) Medicine comprising lysine by-products
KR930702984A (ko) 비-소세포 폐암의 치료
OA09379A (fr) Polyméthylène-imines disubstituées, leur procédé de préparation et les compositions pharmaceutiques les contenant.
GB2019720A (en) S-adenosyl-L-homocysteine and salts thereof for use in therapy
SU1156682A1 (ru) Способ лечени хал зиона
SU980720A1 (ru) Способ лечени больных лепрой
SU718106A1 (ru) Способ лечени туберкулеза легких по а.с.орешкину
JPS5569510A (en) Carcinostatic agent
SU938947A1 (ru) Способ определени терапевтических доз лекарственного препарата
AP105A (en) Treatment of animals.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19980302